Is laser conization adequate for therapeutic excision of adenocarcinoma in situ of the uterine cervix?

被引:7
作者
Akiba, Y
Kubushiro, K
Fukuchi, T
Fujii, T
Tsukazaki, K
Mukai, M
Nozawa, S
机构
[1] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan
[2] Keio Univ, Sch Med, Dept Pathol, Tokyo 1608582, Japan
关键词
adenocarcinoma in situ; laser conization; squamocolumnar junction; uterine cervix; uterine preservation;
D O I
10.1111/j.1447-0756.2005.00279.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Aims: To determine the safety of uterine-preserving operations for adenocarcinoma in situ of the cervix. Methods: Fifteen cases of adenocarcinoma in situ (AIS) were diagnosed using neodymium:yttrium aluminum garnet (Nd:YAG) laser conization. The accuracy of preconization histology or cytology was evaluated in 15 AIS cases. In these AIS cases, we investigated how far the tumor was located from the squamocolumnar junction (SCJ) and the endocervix. Fourteen cases of the 15 AIS-affected patients were treated using laser conization alone. These patients were closely followed up. Results: Precise agreement between preconization diagnosis and conization histology was seen in 46.7% (7/15) of the AIS cases. In 14 of the 15 cases of AIS (93.3%), the tumor was adjacent to the transitional zone, within 3 mm of the SCJ, and in the other case (6.7%), the tumor was between 0 and 5 mm away from the SCJ. In all subjects, cone height was 8-18 mm (mean 13.1 mm). None of the 15 patients showed any recurrence of AIS during follow up ranging from 15 to 75 months (43.1 months on average). Conclusions: Women with AIS who want to preserve their fecundity might be treated with laser conization alone.
引用
收藏
页码:252 / 256
页数:5
相关论文
共 36 条
[1]   ADENOCARCINOMA INSITU OF THE UTERINE CERVIX - A CLINICOPATHOLOGIC STUDY OF 36 CASES [J].
ANDERSEN, ES ;
ARFFMANN, E .
GYNECOLOGIC ONCOLOGY, 1989, 35 (01) :1-7
[2]  
AYER B, 1987, ACTA CYTOL, V31, P397
[3]   Adenocarcinoma in situ of the cervix:: Management and outcome [J].
Azodi, M ;
Chambers, SK ;
Rutherford, TJ ;
Kohorn, EI ;
Schwartz, PE ;
Chambers, JT .
GYNECOLOGIC ONCOLOGY, 1999, 73 (03) :348-353
[4]  
BEREK JS, 1985, OBSTET GYNECOL, V65, P46
[5]   THE ANATOMIC DISTRIBUTION OF CERVICAL ADENOCARCINOMA INSITU - IMPLICATIONS FOR TREATMENT [J].
BERTRAND, M ;
LICKRISH, GM ;
COLGAN, TJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 157 (01) :21-25
[6]  
BOON ME, 1981, CANCER, V48, P768, DOI 10.1002/1097-0142(19810801)48:3<768::AID-CNCR2820480318>3.0.CO
[7]  
2-L
[8]  
BOON ME, 1987, CANCER-AM CANCER SOC, V59, P862, DOI 10.1002/1097-0142(19870215)59:4<862::AID-CNCR2820590434>3.0.CO
[9]  
2-P
[10]  
CHRISTOPHERSON WM, 1979, CANCER, V44, P975, DOI 10.1002/1097-0142(197909)44:3<975::AID-CNCR2820440327>3.0.CO